» » Clinton's US drug price controls unlikely to happen

0
The Nasdaq Biotechnology Index has recently experienced a sharp decline due to political and media outrage led by Hilary Clinton over drug prices causing investors to fear price controls which could cap the profitability level in the industry. We believe the risk is limited and the growth story is unchanged with Q4 having several potential upside catalysts.

from Peter Garnry - Authored content http://ift.tt/1OpI1fN
via IFTTT
ad

Share to:

Enregistrer un commentaire

Emoticon
:) :)) ;(( :-) =)) ;( ;-( :d :-d @-) :p :o :>) (o) [-( :-? (p) :-s (m) 8-) :-t :-b b-( :-# =p~ $-) (b) (f) x-) (k) (h) (c) cheer
Click to see the code!
To insert emoticon you must added at least one space before the code.

Inscription à : Publier les commentaires (Atom)
 
Top